Neurotransmitters

Borner, Tito

Assistant Professor of Biological Sciences

The whole of his research career focuses on deepening our understanding of how nerve cells control food intake under both normal physiological conditions and when conditions go awry, such as when disease sets in. His overarching research goal is to investigate and identify the components and pathways within the central nervous system that mediate anorexia (loss of appetite), nausea, vomiting (emesis), and weight loss in pre-clinical models. This exploration focuses on understanding how these symptoms manifests after various diseases and, importantly, how they can be prevented, which special emphasis on chronic conditions such as cancer and diabetes.

Chang, Karen T.

Associate Professor of Physiology and Neuroscience

Our lab is interested in understanding how neurons communicate with high fidelity to support complex brain functions. We aim to uncover the molecular and cellular mechanisms that enable precise synaptic signaling and to explore how disruptions in these processes contribute to neurodevelopmental and neurodegenerative disorders. Using Drosophila melanogaster as a genetically tractable model system, we integrate electrophysiology, molecular biology, confocal imaging, proteomics, and behavioral analysis to investigate synaptic function and plasticity.

Ching, Christopher

Assistant Professor Of Research Neurology

Dr. Ching’s research focuses on neuroimaging and genomic markers of psychiatric and neurodegenerative disorders. As a core organizing member of the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Consortium, he designs and implements standardized processing and analysis techniques for large-scale neuroimaging studies. He leads the ENIGMA Bipolar Disorder Working Group, an effort pooling data and resources from around the world to improve our understanding of the biological processes driving bipolar disorder, and studies rare copy number variants like 22q11.2 Deletion Syndrome to understand how genetic mutations can lead to increased risk for developing psychiatric illness. He leads several large-scale transdiagnostic neuroimaging and genomic initiatives using machine learning to map common and distinct brain and clinical factors across mental illnesses.

Coba, Marcelo

Associate Professor

Neurodevelopmental neurodegenerative and psychiatric disease are complex brain disorders, and a multitude of genes have been described to contribute to their pathology with different penetrance. Human genetic studies have discovered many genes associated with disease susceptibility that are usually described as risk factors. For each of these disorders, synaptic proteins have been implicated, in particular those involved in synaptic plasticity and protein complexes associated to the post-synaptic density (PSD). Despite these discoveries, there has been a gap in understanding the underlying mechanisms that contribute to cellular dysfunction in these disorders. Our long-term goal is to determine how candidate risk factors are functionally integrated and how mutations affect their function, not individually, but in developmental signaling networks.

Cortes, Constanza

Assistant Professor of Gerontology

We investigate the mechanisms of exercise-associated neuroprotection in the context of aging and Alzheimer's disease. We utilize transgenic exercice-mimetic transgenic mice in combination with running interventions to isolate and prioritize novel 'exerkines' to move into pre-clinical trials. We are also building an 'exercise atlas' of the brain across the lifespan, with the ultimate goal of developing exercise in a pill as a novel intervention for Alzheimer's disease

Craft, Cheryl Mae

Professor of Ophthalmology

My well established vision research program encompasses my passion for discovery and deciphering rod and cone phototransduction mechanisms in health and disease using animal models for retinal degeneration. Throughout my academic career my research discoveries identified key genes in the pineal and retina, including arrestins to maintain normal high acuity vision. Currently, my personal goals include developing alternative therapeutic rescue treatment strategies with replacement gene therapy and in vitro stem cell technology. With Cobrinik and collaborators, we identified key developmental cone regulators controlling retinoblastoma genesis. I strongly believe in the importance of mentoring vision and clinician scientists and providing medical ethical training doctoral and medical students, and society.